2m 2m 2m 2m 2m 2m 2m
CUE BIOPHARMA (CUE)
NASDAQ
$26.88+$0.04 (+0.13%)
Price as of Aug 03, 2026 11:32 AM EDT- $112.7MMarket Cap
- 21.36%1-Year Change
- BiotechnologyIndustry
CUE BIOPHARMA (CUE)
$26.88+$0.04 (+0.13%)
CUE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.84 | ||
Change | -$3.56 (-11.71%) | ||
Open | $29.85 | ||
High | $29.85 | ||
Low | $25.26 | ||
Previous Close | $30.40 | ||
Volume | 474,917 | ||
30-Day Average Volume | 165,339 | ||
1-Week Change | -16.44% | ||
1-Month Change | -14.96% | ||
1-Year Change | 21.36% | ||
3-Year Change | -76.58% | ||
5-Year Change | -91.41% | ||
Fundamentals | |||
Shares Outstanding | 4.2M | ||
Total Assets | $30.9M | ||
Market Cap | $112.7M | ||
Enterprise Value | $106.4M | ||
Period: QTR TTM FY | |||
Revenue | $5.7M | ||
Net Income | -$5.2M | ||
Free Cash Flow | -$11.1M | ||
EBIT | -$5.2M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $19.0M | ||
EPS | -$32.40 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 5 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 04/24/2026 | ||
Earnings & Revenue